Cardio Diagnostics Holdings, Inc. Operating Lease, Expense
Cardio Diagnostics Holdings, Inc. (CDIO) reported Operating Lease, Expense of $60.83 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. operating lease, expense for the quarter ending 2026-06-30 was $60.83K, a 11.76% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. operating lease, expense for the quarter ending 2026-03-31 was $60.83K, a 5.64% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. operating lease, expense for the quarter ending 2025-12-31 was $63.46K, a 36.02% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. operating lease, expense for the quarter ending 2025-09-30 was $47.03K, a 29.45% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. operating lease, expense for fiscal 2025 was $237.01K, a 15.78% increase from fiscal 2024.
- Cardio Diagnostics Holdings, Inc. operating lease, expense for fiscal 2024 was $204.72K, a 48.06% increase from fiscal 2023.
- Cardio Diagnostics Holdings, Inc. operating lease, expense for fiscal 2023 was $138.27K, a 159.20% increase from fiscal 2022.
- Cardio Diagnostics Holdings, Inc. operating lease, expense for fiscal 2022 was $53.34K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $60.83K 10-Q · filed 2026-08-07 | $121.66K 10-Q · filed 2026-08-07 | $185.12K derived: sum of 3 quarters · filed 2026-08-07 | $232.15K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $60.83K 10-Q · filed 2026-05-15 | $124.29K derived: sum of 2 quarters · filed 2026-05-15 | $171.32K derived: sum of 3 quarters · filed 2026-05-15 | $240.26K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $63.46K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $110.49K derived: sum of 2 quarters · filed 2026-03-13 | $179.43K derived: sum of 3 quarters · filed 2026-08-07 | $237.01K 10-K · filed 2026-03-13 |
| 2025-09-30 | $47.03K 10-Q · filed 2025-11-12 | $115.97K derived: sum of 2 quarters · filed 2026-08-07 | $173.56K 10-Q · filed 2025-11-12 | $220.21K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $68.94K 10-Q · filed 2026-08-07 | $126.53K 10-Q · filed 2026-08-07 | $173.18K derived: sum of 3 quarters · filed 2026-08-07 | $239.84K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $57.59K 10-Q · filed 2026-05-15 | $104.24K derived: sum of 2 quarters · filed 2026-05-15 | $170.91K derived: sum of 3 quarters · filed 2026-05-15 | $226.49K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $46.65K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $113.32K derived: sum of 2 quarters · filed 2026-03-13 | $168.90K derived: sum of 3 quarters · filed 2026-03-13 | $204.72K 10-K · filed 2026-03-13 |
| 2024-09-30 | $66.67K 10-Q · filed 2025-11-12 | $122.25K derived: sum of 2 quarters · filed 2025-11-12 | $158.06K 10-Q · filed 2025-11-12 | $198.52K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $55.58K 10-Q · filed 2025-08-14 | $91.40K 10-Q · filed 2025-08-14 | $131.85K derived: sum of 3 quarters · filed 2025-08-14 | $168.82K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $35.82K 10-Q · filed 2025-05-15 | $76.27K derived: sum of 2 quarters · filed 2025-05-15 | $113.24K derived: sum of 3 quarters · filed 2025-05-15 | $147.23K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $40.45K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $77.42K derived: sum of 2 quarters · filed 2025-03-20 | $111.41K derived: sum of 3 quarters · filed 2025-03-20 | $138.27K 10-K · filed 2025-03-20 |
| 2023-09-30 | $36.97K 10-Q · filed 2024-11-13 | $70.96K derived: sum of 2 quarters · filed 2024-11-13 | $97.81K 10-Q · filed 2024-11-13 | $117.17K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $33.99K 10-Q · filed 2024-08-12 | $60.84K 10-Q · filed 2024-08-12 | $80.19K derived: sum of 3 quarters · filed 2024-08-12 | |
| 2023-03-31 | $26.85K 10-Q · filed 2024-05-15 | $46.20K derived: sum of 2 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $19.35K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $53.34K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $33.99K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |